BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwartz MD, Canales JJ, Zucchi R, Espinoza S, Sukhanov I, Gainetdinov RR. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion on Therapeutic Targets 2018;22:513-26. [DOI: 10.1080/14728222.2018.1480723] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Bortnikov N, Semina M, Sukhanov I, Zvartau E, Dravolina O. P.0235 Selectivity of taar1 partial agonist ro5263397 effects on drug- versus non-drug-related behaviors. European Neuropsychopharmacology 2021;53:S170. [DOI: 10.1016/j.euroneuro.2021.10.225] [Reference Citation Analysis]
2 Hopkins SC, Dedic N, Koblan KS. Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans. Transl Psychiatry 2021;11:228. [PMID: 33879769 DOI: 10.1038/s41398-021-01331-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
3 Docherty JR, Alsufyani HA. Pharmacology of Drugs Used as Stimulants. J Clin Pharmacol 2021;61 Suppl 2:S53-69. [PMID: 34396557 DOI: 10.1002/jcph.1918] [Reference Citation Analysis]
4 Decker AM, Brackeen MF, Mohammadkhani A, Kormos CM, Hesk D, Borgland SL, Blough BE. Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist. ACS Chem Neurosci 2022;13:1082-95. [PMID: 35325532 DOI: 10.1021/acschemneuro.2c00086] [Reference Citation Analysis]
5 Liu J, Wu R, Seaman R, Manz KM, Johnson B, Vu J, Huang Y, Zhang Y, Robison AJ, Neve R, Grueter BA, Dietz D, Li J. TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIα activity in the NAc. Mol Psychiatry. [DOI: 10.1038/s41380-022-01448-3] [Reference Citation Analysis]
6 Accorroni A, Rutigliano G, Sabatini M, Frascarelli S, Borsò M, Novelli E, Bandini L, Ghelardoni S, Saba A, Zucchi R, Origlia N. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Thyroid 2020;30:147-60. [PMID: 31709926 DOI: 10.1089/thy.2019.0255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kubicskó K, Farkas Ö. Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N,N-dimethyltryptamine with monoamine oxidase A. Org Biomol Chem 2020;18:9660-74. [PMID: 33215182 DOI: 10.1039/d0ob01118e] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Xu Z, Li Q. TAAR Agonists. Cell Mol Neurobiol 2020;40:257-72. [PMID: 31848873 DOI: 10.1007/s10571-019-00774-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhang Y, Li JT, Wang H, Niu WP, Zhang CC, Zhang Y, Wang XD, Si TM, Su YA. Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice. Pharmacol Res 2021;167:105571. [PMID: 33753244 DOI: 10.1016/j.phrs.2021.105571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jarończyk M, Walory J. Novel Molecular Targets of Antidepressants. Molecules 2022;27:533. [PMID: 35056845 DOI: 10.3390/molecules27020533] [Reference Citation Analysis]
11 Loftis JM, Lasarev M, Shi X, Lapidus J, Janowsky A, Hoffman WF, Huckans M. Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence. PLoS One 2019;14:e0220270. [PMID: 31600226 DOI: 10.1371/journal.pone.0220270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Pahwa M, Sleem A, Elsayed OH, Good ME, El-Mallakh RS. New Antipsychotic Medications in the Last Decade. Curr Psychiatry Rep 2021;23:87. [PMID: 34843030 DOI: 10.1007/s11920-021-01298-w] [Reference Citation Analysis]
13 Rutigliano G, Zucchi R. Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders. Cell Mol Neurobiol 2020;40:239-55. [PMID: 31643000 DOI: 10.1007/s10571-019-00743-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Krogmann A, Peters L, von Hardenberg L, Bödeker K, Nöhles VB, Correll CU. Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities. CNS Spectr 2019;24:38-69. [PMID: 31482779 DOI: 10.1017/S109285291900124X] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 16.5] [Reference Citation Analysis]
15 Galluppi GR, Polhamus DG, Fisher JM, Hopkins SC, Koblan KS. Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34292664 DOI: 10.1002/psp4.12692] [Reference Citation Analysis]
16 Ryan RM, Ingram SL, Scimemi A. Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression. Front Cell Neurosci 2021;15:670346. [PMID: 33927596 DOI: 10.3389/fncel.2021.670346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Takahashi T, Noriaki S, Matsumura M, Li C, Takahashi K, Nishino S. Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs 2018;6:597-610. [DOI: 10.1080/21678707.2018.1521267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Dedic N, Jones PG, Hopkins SC, Lew R, Shao L, Campbell JE, Spear KL, Large TH, Campbell UC, Hanania T, Leahy E, Koblan KS. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D 2 Receptor Mechanism of Action. J Pharmacol Exp Ther 2019;371:1-14. [DOI: 10.1124/jpet.119.260281] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
19 Almeida-Santos D, Duarte AC, Gonçalves I, Ferreira CL, Ferrer I, Ishikawa H, Schwerk C, Schroten H, Santos CRA. Cadaverine and Spermine Elicit Ca2+ Uptake in Human CP Cells via a Trace Amine-Associated Receptor 1 Dependent Pathway. J Mol Neurosci 2021;71:625-37. [PMID: 32816235 DOI: 10.1007/s12031-020-01684-8] [Reference Citation Analysis]
20 Grinchii D, Dremencov E. Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders. Int J Mol Sci 2020;21:E9532. [PMID: 33333774 DOI: 10.3390/ijms21249532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Bugda Gwilt K, González DP, Olliffe N, Oller H, Hoffing R, Puzan M, El Aidy S, Miller GM. Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1). Cell Mol Neurobiol 2020;40:191-201. [DOI: 10.1007/s10571-019-00772-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Francesconi V, Cichero E, Kanov EV, Laurini E, Pricl S, Gainetdinov RR, Tonelli M. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals (Basel) 2020;13:E391. [PMID: 33202687 DOI: 10.3390/ph13110391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
23 Nataf S, Pays L. Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis. Int J Mol Sci 2021;22:10440. [PMID: 34638785 DOI: 10.3390/ijms221910440] [Reference Citation Analysis]
24 Decker AM, Mathews KM, Blough BE, Gilmour BP. Validation of a High-Throughput Calcium Mobilization Assay for the Human Trace Amine-Associated Receptor 1. SLAS Discov 2021;26:140-50. [PMID: 32734809 DOI: 10.1177/2472555220945279] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kantrowitz JT. Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions. CNS Drugs 2021;35:1153-61. [PMID: 34655036 DOI: 10.1007/s40263-021-00864-3] [Reference Citation Analysis]
26 Rutigliano G, Bräunig J, Del Grande C, Carnicelli V, Masci I, Merlino S, Kleinau G, Tessieri L, Pardossi S, Paisdzior S, Dell'Osso L, Biebermann H, Zucchi R. Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders. Front Pharmacol 2019;10:1027. [PMID: 31572197 DOI: 10.3389/fphar.2019.01027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
27 Wu R, Liu J, Johnson B, Huang Y, Zhang Y, Li JX. Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects. Addict Biol 2022;27:e13075. [PMID: 34170054 DOI: 10.1111/adb.13075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tonelli M, Cichero E. Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present). Expert Opinion on Therapeutic Patents 2020;30:137-45. [DOI: 10.1080/13543776.2020.1708900] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
29 Freyberg Z, Saavedra JM. Trace Amines and Trace Amine-Associated Receptors: A New Frontier in Cell Signaling. Cell Mol Neurobiol 2020;40:189-90. [PMID: 32006222 DOI: 10.1007/s10571-020-00800-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]